IP Library Granted Patent US 7,385,086
Granted Patent B2
US 7,385,086 · App. 10/764,451 · Granted Jun 10, 2008

Antimicrobial compounds

Assignee: The Johns Hopkins University School of Medicine
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,385,086
App. No.
10/764,451
Granted
Jun 10, 2008
Kind
B2
Abstract

This invention provides compounds and methods for treating, with said compound, a mycobacterial infection by administering to an animal a pharmaceutical composition containing a compound having the formula R—SO n -Z-CO—Y, where R is an alkyl groups having 6-20 carbon atoms, unsaturated hydrocarbon groups having 6-20 carbon atoms, or alkyl groups having 6-20 carbon atoms interrupted by at least one aromatic ring; Z is —CH 2 —, —CH 2 CH 2 —, —NH—NH—, —O—, ——NH—, —O—NH—, —CH 2 —NH—, —CH 2 —O—, —NH—O—, —NH—CH 2 —, —O—CH 2 —, and —CH═CH—; Y is —NH 2 , —O—CH 2 —C 6 H 5 , —CO—CO—O—CH 3 , and —O—CH 3 ; and n is 1 or 2. It has been discovered that these compounds treat microbially-based infections caused by corynebacteria, nocardiae, rhodococcus, and mycobacteria. These compounds may be used to treat mycobacterial cells, such as Mycobacteria tuberculosis , drug resistant M. tuberculosis, M. avium intracellulare, M. leprae, M. paratuberculosis , and pathogenic Mycobacteria sp.

Claims (18)

1. A method of inhibiting growth of a mycobacterial cell, comprising administering an effective amount of a compound of formula I to the cell:

R—SO n -Z-CO—Y  I

wherein:

R is selected from the group consisting of any alkyl group having from 6-10 carbon atoms, any unsaturated hydrocarbon having from 6-10 carbon atoms, or any alkyl group having from 6-10 carbon atoms interrupted by at least one aromatic ring;

Z is —CH 2 —;

Y is selected from the group consisting of —NH 2 , and —O—CH 3 ; and

n is 1 or 2;

and wherein, the mycobacterial cell is selected from the group consisting of cells of Mycobacteria tuberculosis , drug resistant M. tuberculosis, M. bovis, M. leprae , and M. paratuberculosis.

2. The method of claim 1 , wherein R is an alkyl group having 6-10 carbon atoms interrupted by an aromatic ring to give ortho-, meta-, or para-disubstitution.

3. The method of claim 1 , wherein R is a branched alkyl group.

4. The method of claim 1 , wherein R is an n-alkyl group.

5. The method of claim 1 , wherein n is 1.

6. The method of claim 1 , wherein n is 2.

7. The method of claim 1 , wherein Y is —NH 2 .

8. The method of claim 1 , wherein: R is —(CH 2 ) 9 —CH 3 , n is 1, Z is —CH 2 — and Y is —NH 2 .

9. The method of claim 1 , wherein: R is —(CH 2 ) 7 —CH 3 , n is 1, Z is —CH 2 — and Y is —NH 2 .

10. The method of claim 1 , wherein: R is —(CH 2 ) 9 —CH 3 , n is 2, Z is —CH 2 — and Y is —NH 2 .

11. The method of claim 1 , wherein: R is —(CH 2 ) 7 —CH 3 , n is 2, Z is CH 2 — and Y is —NH 2 —.

Assignments (3)
NUNC PRO TUNC ASSIGNMENT Recorded Jul 20, 2015
From: D. E. DURAND FAMILY LIMITED PARTNERSHIP
To: FAS SECURED CREDITORS HOLDCO, LLC
Reel/Frame 036137/0683 →
FORECLOSURE - CONVEYANCE OF ENTIRE INTEREST OF ASSIGNOR. Recorded May 5, 2015
From: D. E. DURAND FAMILY LIMITED PARTNERSHIP, SECURED PARTY IN POSSESSION
To: D. E. DURAND FAMILY LIMITED PARTNERSHIP
Reel/Frame 035582/0615 →
SECURITY INTEREST Recorded Apr 29, 2015
From: FASGEN, INC.
To: D.E. DURAND FAMILY LIMITED PARTNERSHIP
Reel/Frame 035528/0774 →
Continuity (3)
Division 0948655000
Provisional Application 6005627200 · Aug 29, 1997
Related Publication 20040186176A1 · Sep 23, 2004